metoprolol and carvedilol in therapy of acute myocardial infarction: when and which drug to prefer
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

metoprolol and carvedilol in therapy of acute myocardial infarction: when and which drug to prefer

;B. N. Garifullin;A. N. Zakirova;F. S. Zarudij
environmental technology 2016 Vol. 5 pp. 51-57
231
garifullin2016racionalnametoprolol

Abstract

Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed. Last changes in guidelines regarding beta-blockers prescription to patients with MI are presented. Data of the studies comparing influence of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment schemes for carvedilol in patients with acute MI are discussed.

Keywords

pharmacologydiseases of the circulatory (cardiovascular) system метопрололtherapeutics

Access

DOI:
10.1234/1819-6446-2009-4-51-57
URL:
http://www.rpcardio.ru/jour/article/view/686

Citation

ID: 157367
Ref Key: garifullin2016racionalnametoprolol
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
157367
Unique Identifier:
10.1234/1819-6446-2009-4-51-57
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store